
    <!DOCTYPE html>
    <html>
    <head>
        <style>
            body { 
                font-family: 'Segoe UI', Roboto, -apple-system, sans-serif; 
                max-width: 1200px; 
                margin: 0 auto; 
                padding: 20px; 
                background-color: #f0f2f5;
                line-height: 1.6;
            }
            .container { 
                background-color: white; 
                padding: 40px; 
                border-radius: 16px; 
                box-shadow: 0 4px 12px rgba(0,0,0,0.1);
            }
            .agent-section { 
                margin-bottom: 35px; 
                padding: 25px; 
                border-radius: 12px; 
                transition: all 0.3s ease;
            }
            .agent-section:hover {
                transform: translateY(-2px);
                box-shadow: 0 4px 15px rgba(0,0,0,0.1);
            }
            .final-annotation { 
                background-color: #f0f7ff; 
                border-left: 5px solid #2196f3; 
            }
            .validator { 
                background-color: #f0fdf4; 
                border-left: 5px solid #22c55e; 
            }
            .formatting { 
                background: linear-gradient(145deg, #fff7ed, #ffe4c4);
                border-left: 5px solid #f97316; 
                box-shadow: 0 4px 15px rgba(249, 115, 22, 0.1);
            }
            h2 { 
                color: #1a2b3c; 
                margin-top: 0; 
                font-size: 1.5rem;
                font-weight: 600;
                display: flex;
                align-items: center;
                gap: 10px;
            }
            ul { 
                margin: 15px 0; 
                padding-left: 20px; 
            }
            pre { 
                background-color: #f8fafc; 
                padding: 20px; 
                border-radius: 8px; 
                overflow-x: auto;
                font-family: 'Consolas', 'Monaco', monospace;
                font-size: 0.9rem;
                line-height: 1.5;
            }
            .validation-result { 
                font-weight: 600; 
                color: #16a34a; 
                padding: 12px 20px;
                background-color: #dcfce7; 
                border-radius: 8px; 
                display: inline-block;
                margin: 10px 0;
            }
            br { 
                margin-bottom: 8px; 
            }
            p {
                margin: 12px 0;
                color: #374151;
            }
            .summary-content {
                display: flex;
                flex-direction: column;
                gap: 24px;
            }
            .summary-item {
                display: flex;
                flex-direction: column;
                gap: 8px;
                background: rgba(255, 255, 255, 0.7);
                padding: 16px;
                border-radius: 12px;
                backdrop-filter: blur(8px);
                box-shadow: 0 2px 8px rgba(0, 0, 0, 0.05);
            }
            .summary-label {
                font-weight: 600;
                color: #c2410c;
                font-size: 0.95rem;
                text-transform: uppercase;
                letter-spacing: 0.5px;
            }
            .summary-value {
                color: #1f2937;
                font-size: 1.1rem;
                padding: 8px 16px;
                background-color: rgba(255, 255, 255, 0.9);
                border-radius: 8px;
                display: inline-block;
                box-shadow: 0 1px 3px rgba(0, 0, 0, 0.1);
            }
            .summary-list {
                margin: 0;
                padding-left: 24px;
                list-style-type: none;
            }
            .summary-list li {
                color: #1f2937;
                padding: 8px 0;
                position: relative;
            }
            .summary-list li:before {
                content: "‚Ä¢";
                color: #f97316;
                font-weight: bold;
                position: absolute;
                left: -20px;
            }
            .report-header {
                text-align: center;
                margin-bottom: 40px;
                padding-bottom: 30px;
                border-bottom: 2px solid rgba(249, 115, 22, 0.2);
            }
            
            .report-title {
                font-size: 2.5rem;
                font-weight: 800;
                color: #1a2b3c;
                margin: 0;
                padding: 0;
                background: linear-gradient(135deg, #f97316, #c2410c);
                -webkit-background-clip: text;
                -webkit-text-fill-color: transparent;
                letter-spacing: -0.5px;
            }
            
            .report-subtitle {
                font-size: 1.1rem;
                color: #64748b;
                margin-top: 8px;
                font-weight: 500;
            }
            .scoring { 
                background: linear-gradient(145deg, #f0fdf4, #dcfce7);
                border-left: 5px solid #22c55e;
                box-shadow: 0 4px 15px rgba(34, 197, 94, 0.1);
            }
            .scoring-content {
                display: flex;
                flex-direction: column;
                gap: 16px;
                color: #1f2937;
                line-height: 1.8;
            }
            .scoring-content br + br {
                content: "";
                display: block;
                margin: 12px 0;
            }
            .empty-list {
                color: #6b7280;
                font-style: italic;
            }
            .error-message {
                color: #dc2626;
                padding: 12px;
                background-color: #fef2f2;
                border-radius: 6px;
                border-left: 4px solid #dc2626;
            }
            .score-badge {
                background: linear-gradient(135deg, #22c55e, #16a34a);
                color: white;
                padding: 8px 16px;
                border-radius: 12px;
                font-size: 1.5rem;
                font-weight: 700;
                display: inline-block;
                margin: 12px 0;
                box-shadow: 0 4px 12px rgba(34, 197, 94, 0.2);
                position: relative;
                top: -10px;
            }
            .score-badge::before {
                content: "Score:";
                font-size: 0.9rem;
                font-weight: 500;
                margin-right: 8px;
                opacity: 0.9;
            }
        </style>
    </head>
    <body>
        <div class="container">
            <div class="report-header">
                <h1 class="report-title">CASSIA Analysis Report</h1>
                <p class="report-subtitle">Comprehensive Cell Type Analysis and Annotation</p>
            </div>
            
                <div class="agent-section final-annotation">
                    <h2>üîç Final Annotation Analysis</h2>
                    To annotate the cell type from the provided ranked marker list, we will follow the outlined steps:<br><br>### Step 1: List the Key Functional Markers<br>- **KRT6A, KRT14, KRT17, KRT6B, KRT5**: These are keratins, which are structural proteins typically expressed in epithelial cells. They play a role in the structural integrity and function of epithelial tissues.<br>- **SERPINB5 (Maspin)**: A serine protease inhibitor involved in tumor suppression and regulation of cell adhesion.<br>- **SAA1 (Serum Amyloid A1)**: An acute-phase protein involved in inflammation and immune response.<br>- **S100P, S100A9**: Members of the S100 family of proteins, involved in calcium binding and regulation of a variety of cellular processes including cell cycle progression and differentiation.<br>- **SOX9**: A transcription factor involved in the regulation of developmental processes and differentiation, particularly in chondrogenesis and stem cell maintenance.<br>- **CLDN4 (Claudin 4)**: A component of tight junction strands, important for maintaining cell polarity and barrier function in epithelial cells.<br>- **ANXA2 (Annexin A2)**: Involved in membrane organization and dynamics, and plays a role in cellular processes such as endocytosis and exocytosis.<br>- **LGALS3 (Galectin-3)**: Involved in cell-cell and cell-matrix interactions, apoptosis, and immune response modulation.<br><br>### Step 2: List the Key Cell Type Markers<br>- **KRT5, KRT14, KRT17**: These keratins are typically associated with basal epithelial cells, particularly basal-like cells in the breast.<br>- **FDCSP (Follicular Dendritic Cell Secreted Protein)**: Although primarily associated with follicular dendritic cells, its expression in this context may indicate a role in the tumor microenvironment.<br>- **SLPI (Secretory Leukocyte Peptidase Inhibitor)**: Expressed in epithelial tissues, particularly in the respiratory and reproductive tracts, and has roles in immune response and inflammation.<br>- **TACSTD2 (TROP2)**: A cell surface glycoprotein expressed in various epithelial tissues and often upregulated in cancers, including breast cancer.<br>- **LY6K**: Overexpressed in various cancers, including breast cancer, and associated with tumor progression.<br><br>### Step 3: Cross-reference Known Databases<br>Using databases such as the Human Protein Atlas, CellMarker, and literature on breast cancer scRNA-seq, we can cross-reference these markers:<br>- **Basal-like breast cancer cells**: Known to express high levels of KRT5, KRT14, and KRT17.<br>- **Epithelial cells**: Express keratins and markers like CLDN4, TACSTD2, and SLPI.<br>- **Cancer-associated markers**: SERPINB5, SAA1, and LY6K are often upregulated in breast cancer tissues.<br><br>### Step 4: Determine the Most Probable General Cell Type<br>Based on the expression of keratins (KRT5, KRT14, KRT17) and other epithelial markers (CLDN4, TACSTD2), the most probable general cell type is **epithelial cells**, specifically those associated with the basal layer.<br><br>### Step 5: Identify the Top 3 Most Probable Sub Cell Types<br>1. **Basal-like Epithelial Cells**: High expression of KRT5, KRT14, and KRT17 strongly suggests basal-like epithelial cells, common in basal-like breast cancer.<br>2. **Luminal Progenitor Cells**: While less likely, some markers like TACSTD2 and S100P can also be expressed in luminal progenitor cells.<br>3. **Cancer Stem-like Cells**: The presence of markers like SOX9 and LY6K may indicate a stem-like or progenitor state within the cancerous tissue.<br><br>The most likely subtype based on the markers is **Basal-like Epithelial Cells**.<br><br>### Step 6: Provide a Concise Summary of Your Analysis<br>The analysis of the ranked marker list from the breast cancer tissue dataset suggests that the cell cluster is most likely composed of basal-like epithelial cells. This is supported by the high expression of basal keratins (KRT5, KRT14, KRT17) and other epithelial markers. These cells are characteristic of basal-like breast cancer, a subtype known for its aggressive nature and distinct molecular profile.<br><br>FINAL ANNOTATION COMPLETED
                </div>
            
                <div class="agent-section validator">
                    <h2>‚úì Validation Check</h2>
                    <div class="validation-result">‚úÖ VALIDATION PASSED</div>
                    Validation result: VALIDATION PASSED<br><br>The proposed annotation result is consistent with the provided marker list and the identified cell type. Here's the breakdown:<br><br>1. **Marker Consistency**: <br>   - The key functional markers and cell type markers listed in the annotation are present in the provided marker list. <br>   - The markers KRT5, KRT14, and KRT17 are indeed associated with basal epithelial cells, particularly in the context of basal-like breast cancer, which aligns with the annotation of basal-like epithelial cells.<br>   - Other markers such as CLDN4, TACSTD2, and SLPI support the epithelial nature of the cells, while markers like LY6K and SOX9 suggest a cancerous or stem-like state, which is consistent with the context of breast cancer.<br><br>2. **Mixed Cell Type Consideration**:<br>   - The annotation considers the possibility of mixed cell types by identifying potential subtypes such as luminal progenitor cells and cancer stem-like cells. However, the strongest evidence supports the basal-like epithelial cell type, which is appropriate given the marker expression profile.<br><br>Overall, the annotation is well-supported by the marker list and the context provided, leading to a valid conclusion of basal-like epithelial cells as the primary cell type in the cluster.
                </div>
            
                        <div class="agent-section formatting">
                            <h2>üìã Summary</h2>
                            
                        <div class="summary-content">
                            <div class="summary-item">
                                <span class="summary-label">Main Cell Type:</span>
                                <span class="summary-value">Epithelial Cells</span>
                            </div>
                            
                            <div class="summary-item">
                                <span class="summary-label">Sub Cell Types:</span>
                                <ul class="summary-list">
                                    <li>Basal-like Epithelial Cells</li><li>Luminal Progenitor Cells</li><li>Cancer Stem-like Cells</li>
                                </ul>
                            </div>
                            
                            <div class="summary-item">
                                <span class="summary-label">Possible Mixed Cell Types:</span>
                                <ul class="summary-list">
                                    <li class="empty-list">No mixed cell types identified</li>
                                </ul>
                            </div>
                            
                            <div class="summary-item">
                                <span class="summary-label">Number of Markers:</span>
                                <span class="summary-value">50</span>
                            </div>
                        </div>
                    
                        </div>
                    
                    <div class="agent-section scoring">
                        <h2>üéØ Quality Assessment</h2>
                        <div class="score-badge">90</div>
                        <div class="scoring-content">
                            The annotation results provided demonstrate a thorough and methodical approach to identifying the cell types present in the single-cell dataset derived from human breast cancer. The analysis is well-structured, following a logical sequence of steps that include listing key functional and cell type markers, cross-referencing with known databases, and determining the most probable cell types.<br><br>1. **Correctness of the Annotations**: The annotation correctly identifies the primary cell type as epithelial cells, specifically basal-like epithelial cells, which is consistent with the high expression of keratins KRT5, KRT14, and KRT17. These markers are well-known indicators of basal-like breast cancer, supporting the accuracy of the annotation.<br><br>2. **Balanced Consideration of Multiple Markers**: The analysis effectively balances the use of various markers, considering both structural proteins (keratins) and other functional markers like SERPINB5, SAA1, and SOX9. This comprehensive approach ensures that the annotation is not overly reliant on a single marker but instead considers a range of markers that contribute to the cell type identification.<br><br>3. **Ability to Capture the General Picture**: The annotation captures the general picture of the cell populations by considering potential subtypes such as luminal progenitor cells and cancer stem-like cells. This reflects an understanding of the complexity and heterogeneity of breast cancer tissues, where multiple cell types and states may coexist.<br><br>4. **Consideration of Marker Rank**: While the annotation does not explicitly discuss the rank of markers, it does prioritize key markers like KRT5, KRT14, and KRT17, which appear early in the list and are crucial for identifying basal-like epithelial cells. This suggests an implicit consideration of marker importance based on their position in the list.<br><br>5. **Potential Oversights**: One potential oversight is the lack of explicit discussion on the rank of markers, which could have strengthened the analysis by highlighting the most critical markers. Additionally, while the annotation considers mixed cell types, it could have further explored the implications of markers like FDCSP, which are less typical for epithelial cells but may indicate interactions with the tumor microenvironment.<br><br>Overall, the annotation is scientifically accurate, well-balanced, and provides a comprehensive view of the cell types present in the dataset. It effectively captures the complexity of the data while maintaining a focus on the most relevant markers for breast cancer.<br>
                        </div>
                    </div>
                
        </div>
    </body>
    </html>
    